04-08-2021, 11:35 PM
https://www.straitstimes.com/singapore/h...inst-delta
One of the resulting combinations was a dynamic duo consisting of Merck and Ridgeback Biotherapeutic's novel antiviral drug, molnupiravir, combined with baricitinib, an anti-inflammatory drug.
One of the resulting combinations was a dynamic duo consisting of Merck and Ridgeback Biotherapeutic's novel antiviral drug, molnupiravir, combined with baricitinib, an anti-inflammatory drug.